American Century Companies
FDMT icon

American Century Companies’s 4D Molecular Therapeutics FDMT Stock Holding History

American Century Companies’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$945K Buy
101,511
+10,427
+11% +$90.7K ﹤0.01% 2347
2025
Q4 		$683K Buy
91,084
+21,465
+31% +$218K ﹤0.01% 2430
2025
Q3 		$605K Buy
69,619
+20,809
+43% +$124K ﹤0.01% 2456
2025
Q2 		$181K Buy
48,810
+5,026
+11% +$17.7K ﹤0.01% 2751
2025
Q1 		$141K Buy
43,784
+4,999
+13% +$23.6K ﹤0.01% 2800
2024
Q4 		$216K Buy
38,785
+4,429
+13% +$34.8K ﹤0.01% 2770
2024
Q3 		$371K Buy
34,356
+21,569
+169% +$358K ﹤0.01% 2572
2024
Q2 		$268K Buy
+12,787
New +$321K ﹤0.01% 2668

Other funds holding FDMT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return